These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12500070)

  • 21. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
    Gray NS
    Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute dystonia after initial doses of ziprasidone: a case report.
    Yumru M; Savas HA; Selek S; Savas E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):745-7. PubMed ID: 16580766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 25. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
    Ku HL; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):963-4. PubMed ID: 16624468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone.
    Kinzie E; Meltzer-Brody S
    Gen Hosp Psychiatry; 2005; 27(3):223-4. PubMed ID: 15882772
    [No Abstract]   [Full Text] [Related]  

  • 27. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
    Scahill L; Blair J; Leckman JF; Martin A
    J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441
    [No Abstract]   [Full Text] [Related]  

  • 28. Ziprasidone-associated depressive state in schizophrenic patients.
    Kaptsan A; Dwolatzky T; Lerner V
    Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation induced by high-dose ziprasidone: a case report.
    Kaushik S; Maccabee N; Kaushik S; Lindenmayer JP
    J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
    [No Abstract]   [Full Text] [Related]  

  • 30. Galactorrhea with aripiprazole.
    Mendhekar DN; Andrade C
    Can J Psychiatry; 2005 Mar; 50(4):243. PubMed ID: 15898468
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probable association between ziprasidone and worsening hypertension.
    Villanueva N; Markham-Abedi C; McNeely C; Diaz FJ; de Leon J
    Pharmacotherapy; 2006 Sep; 26(9):1352-7. PubMed ID: 16945059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of ziprasidone associated with acutely worsened diabetes mellitus.
    Honigberg MC; Bui MP; Coconcea C
    Psychosomatics; 2013; 54(3):304-5. PubMed ID: 23680062
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ziprasidone and dementia].
    Aakhus E
    Tidsskr Nor Laegeforen; 2004 Aug; 124(16):2155-6; author reply 2155-6. PubMed ID: 15334150
    [No Abstract]   [Full Text] [Related]  

  • 36. Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
    Kim MS; Kim SW; Han TY; Son SJ; Lee JH; Kim EJ
    Int J Dermatol; 2014 Apr; 53(4):e267-8. PubMed ID: 24117439
    [No Abstract]   [Full Text] [Related]  

  • 37. Transient, asymptomatic, fluctuating bradycardia with oral ziprasidone in an older woman.
    Menon V; Ramamourthy P; Ayyanar S
    Aust N Z J Psychiatry; 2014 Feb; 48(2):201-2. PubMed ID: 23934959
    [No Abstract]   [Full Text] [Related]  

  • 38. Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
    Kelly DL; Love RC
    Psychopharmacol Bull; 2001; 35(4):66-79. PubMed ID: 12397857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis.
    Akkaya C; Sarandol A; Sivrioglu EY; Kotan Z; Kirli S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1535-8. PubMed ID: 16820256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrapyramidal symptoms in children on atypical antipsychotic drugs.
    Sathpathy S; Winsberg B
    J Clin Psychopharmacol; 2003 Dec; 23(6):675-7. PubMed ID: 14624205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.